Markets rallied Wednesday after hearing news of positive test results of Gilead‘s remdesivir‘s drug treatment COVID-19 patients. Though more testing is needed before remdesivir can be used anywhere, the hopeful news lifted markets. Gildea stock spiked 5.7%. In fact, indices […]